Avdoralimab Biosimilar - Research Grade

Human

C5AR1ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P21730

Blue ice

C5aR1 (C5AR1) is the receptor for the complement anaphylatoxin C5a and a key driver of inflammatory cell recruitment studied across immunology research. This anti-human C5AR1 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of avdoralimab, provided strictly for research use only. Built to rigorous in vivo standards and low in endotoxin, it is manufactured in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. It serves as a dependable control and active reagent in receptor-blockade assays, in vitro functional screening, and in vivo models of complement-mediated inflammation, with lot-to-lot consistency.

C5A, C5AR, C5R1, CD88, complement component 5a receptor 1, C5a receptor, complement C5a receptor 1

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks